Skip to content

Effect of Naturopathic Treatments On Anxiety Outcomes of Postal Workers, a randomized controlled parallel group study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78958974
Enrollment
86
Registered
2007-03-28
Start date
2006-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Mental and Behavioural Disorders Anxiety

Interventions

Herb: withania somnifera and multivitamin vs placebo

Sponsors

The Canadian College of Naturopathic Medicine (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and females aged 18-65 that are Canada Post employees and members of Canadian Union of Postal Workers (CUPW). 2. Mentally competent subjects able to adhere to the given protocol and treatments administered as interventions. 3. Self-selected candidates identifying themselves to suffer from the symptoms of stress and anxiety for a period of 6 weeks or more and a score of at least 10 on the Beck Anxiety Inventory (BAI) at the pre-study intake. 4. Normal on physical examination at the pre-study intake, and in the case of abnormalities the medical practitioner considers them to be clinically insignificant. 5. Written and informed consent. 6. The potential candidate must have a family doctor that they have seen in the last 12 months. 7. A negative pregnancy test for menstruating women and a willingness to practice adequate birth control for the duration of the trial

Exclusion criteria

Exclusion criteria: 1. Mentally or physically incapacitated such that informed consent cannot be obtained. 2. Any history or other condition which the study physician regards as clinically significant to the study (including allergies or sensitivities to withanolides or multivitamins, gastritis or peptic ulcer). 3. A major illness considered to be clinically significant by the study physician within 3 months of the study start date. 4. Current participation in another intervention trial. 5. Pregnancy or intent to become pregnant in the next 6 months. 6. Medication at doses that is contraindicated with herb/multi-vitamin. (specifically daily use of benzodiazepene class drugs.) 7. Current alcoholism or substance abuse (sedative) 8. Current history of tumors. 9. Any current serious disorders determined to be clinically significant to the study. 10. Scoring above 20 on the Beck Depression Inventory. 11. Breast feeding women

Design outcomes

Primary

MeasureTime frame
1. Beck Anxiety Inventory 2. Fatique Questionnaire

Secondary

MeasureTime frame
1. SF-36 Questionnaire 2. Weight 3. Body Mass Index (BMI)

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026